BGB-A317-290-LTE1
Active, not recruiting
Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced Malignancies
BeOne Study ID
BGB-A317-290-LTE1
ClinicalTrials.gov ID
EudraCT or EUCT Number
2023-508883-31-00
Study Overview
Sex: All
Age: 18 Years / N/A
Accepts Healthy Volunteers? No
No Study Documents
Study Overview
Sex: All
Age: 18 Years / N/A
Accepts Healthy Volunteers? No
No Study Documents